Increased utilization of postmastectomy radiotherapy in the United States from 2003 to 2011 in patients with one to three tumor positive nodes

Journal of Surgical Oncology

Volumn 112, Issue 8, 2015, Pages 809-814

  Yao, Katharine ^a   Liederbach, Erik ^a   Lutfi, Waseem ^a   Wang, Chi Hsiung ^a   Hou, Ningqi ^b   Karrison, Theodore ^b   Huo, Dezheng ^b  

^a NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

chest wall radiation; postmastectomy; radiation

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; COMPUTER ASSISTED RADIOTHERAPY; DATA BASE; EXTERNAL BEAM RADIOTHERAPY; HEALTH CARE UTILIZATION; HISTOPATHOLOGY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LOGISTIC REGRESSION ANALYSIS; LOGLINEAR MODEL; LYMPH NODE; LYMPH VESSEL METASTASIS; MAJOR CLINICAL STUDY; MASTECTOMY; MIDDLE AGED; PHENOTYPE; POSTMASTECTOMY RADIOTHERAPY; PREDICTOR VARIABLE; PRIORITY JOURNAL; TUMOR VOLUME; UNITED STATES; YOUNG ADULT; ADJUVANT RADIOTHERAPY; BREAST NEOPLASMS; CARCINOMA; FEMALE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; PATHOLOGY; RETROSPECTIVE STUDY; SECONDARY; STATISTICAL MODEL; UTILIZATION;

ADULT; AGED; BREAST NEOPLASMS; CARCINOMA; FEMALE; HUMANS; LINEAR MODELS; LOGISTIC MODELS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MASTECTOMY; MIDDLE AGED; NEOPLASM STAGING; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 84955177706     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.24071     Document Type: Article

References (34)

1. Overgaard M, Hansen PS, Overgaard J, et al.,: Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Eng J Med 1997; 337: 949-955.
2. Overgaard M, Jensen MB, Overgaard J, et al.,: Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet 1999; 353: 1641-1648.
3. Ragaz J, Olivotto IA, Spinelli JJ, et al.,: Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial. J Natl Cancer Inst 2005; 97: 116-126.
4. Recht A, Edge SB, Solin LJ, et al.,: Postmastectomy radiotherapy: Clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 2001; 19: 1539-1569.
5. Eifel P, Axelson JA, Costa J, et al.,: National Institutes of Health Consensus Development Conference Statement: Adjuvant therapy for breast cancer, November 1-3, 2000. J Natl Cancer Inst 2001; 93: 979-989.
6. NCCN Clinical Practice Guidelines in Oncology: Breast Cancer NCCN. In, 2011.
7. McGale P, Taylor C, Correa C, et al.,: Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: Meta-analysis of individual patient data for 8135 women in 22 randomised trials. Lancet 2014; 383: 2127-2135.
8. Poortmans PM, Collette S, Kirkove C, et al.,: Internal mammary and medial supraclavicular irradiation in breast cancer. N Eng J Med 2015; 373: 317-327.
9. Whelan TJ, Olivotto IA, Parulekar WR, et al.,: Regional nodal irradiation in early-stage breast cancer. N Eng J Med 2015; 373: 307-316.
10. Punglia RS, Hughes ME, Edge SB, et al.,: Factors associated with guideline-concordant use of radiotherapy after mastectomy in the national comprehensive cancer network. Int J Radiat Oncol Biol Phys 2008; 72: 1434-1440.
11. Smith BD, Haffty BG, Hurria A, et al.,: Postmastectomy radiation and survival in older women with breast cancer. J Clin Oncol 2006; 24: 4901-4907.
12. Smith BD, Smith GL, Haffty BG,: Postmastectomy radiation and mortality in women with T 1-2 node-positive breast cancer. J Clin Oncol 2005; 23: 1409-1419.
13. Dragun AE, Huang B, Gupta S, et al.,: One decade later: Trends and disparities in the application of post-mastectomy radiotherapy since the release of the American Society of Clinical Oncology clinical practice guidelines. Int J Radiat Oncol Biol Phys 2012; 83: e591-e596.
14. Huo D, Hou N, Jaskowiak N, et al.,: Use of postmastectomy radiotherapy and survival rates for breast cancer patients with T1-T2 and one to three positive lymph nodes. Ann Surg Oncol 2015.
15. Giuliano AE, McCall L, Beitsch P, et al.,: Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: The American College of Surgeons Oncology Group Z0011 randomized trial. Ann Surg 2010; 252: 426-432; discussion 432-423.
16. Yao K, Liederbach E, Pesce C, et al.,: Impact of the American College of Surgeons Oncology Group Z0011 randomized trial on the number of axillary nodes removed for patients with early-stage breast cancer. J Am Coll Surg 2015; 221: 71-81.
17. Deyo RA, Cherkin DC, Ciol MA,: Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992; 45: 613-619.
18. Pesce CE, Liederbach E, Czechura T, et al.,: Changing surgical trends in young patients with early stage breast cancer, 2003 to 2010: A report from the National Cancer Data Base. J Am Coll Surg 2014; 219: 19-28.
19. Census US: Census Regions and Divisions of the United States. Available at: http://www2.census.gov/geo/pdfs/maps-data/maps/reference/us-regdiv.pdf. Accessed September 1, 2015.
20. Shirvani SM, Pan IW, Buchholz TA, et al.,: Impact of evidence-based clinical guidelines on the adoption of postmastectomy radiation in older women. Cancer 2011; 117: 4595-4605.
21. Jagsi R, Abrahamse P, Morrow M, et al.,: Patterns and correlates of adjuvant radiotherapy receipt after lumpectomy and after mastectomy for breast cancer. J Clin Oncol 2010; 28: 2396-2403.
22. McBride A, Allen P, Woodward W, et al.,: Locoregional recurrence risk for patients with T1,2 breast cancer with 1-3 positive lymph nodes treated with mastectomy and systemic treatment. Int J Radiat Oncol Biol Phys 2014; 89: 392-398.
23. Giuliano AE, Hunt KK, Ballman KV, et al.,: Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: A randomized clinical trial. JAMA 2011; 305: 569-575.
24. Moo TA, McMillan R, Lee M, et al.,: Selection criteria for postmastectomy radiotherapy in t1-t2 tumors with 1 to 3 positive lymph nodes. Ann Surg Oncol 2013; 20: 3169-3174.
25. Taghian A, Jeong JH, Mamounas E, et al.,: Patterns of locoregional failure in patients with operable breast cancer treated by mastectomy and adjuvant chemotherapy with or without tamoxifen and without radiotherapy: Results from five National Surgical Adjuvant Breast and Bowel Project randomized clinical trials. J Clin Oncol 2004; 22: 4247-4254.
26. Recht A, Gray R, Davidson NE, et al.,: Locoregional failure 10 years after mastectomy and adjuvant chemotherapy with or without tamoxifen without irradiation: Experience of the Eastern Cooperative Oncology Group. J Clin Oncol 1999; 17: 1689-1700.
27. Katz A, Strom EA, Buchholz TA, et al.,: Locoregional recurrence patterns after mastectomy and doxorubicin-based chemotherapy: Implications for postoperative irradiation. J Clin Oncol 2000; 18: 2817-2827.
28. Giordano SH, Kuo YF, Freeman JL, et al.,: Risk of cardiac death after adjuvant radiotherapy for breast cancer. J Natl Cancer Inst 2005; 97: 419-424.
29. Truong PT, Lesperance M, Culhaci A, et al.,: Patient subsets with T1-T2, node-negative breast cancer at high locoregional recurrence risk after mastectomy. Int J Radiat Oncol Biol Phys 2005; 62: 175-182.
30. Moo TA, McMillan R, Lee M, et al.,: Impact of molecular subtype on locoregional recurrence in mastectomy patients with T1-T2 breast cancer and 1-3 positive lymph nodes. Ann Surg Oncol 2014; 21: 1569-1574.
31. Truong PT, Sadek BT, Lesperance MF, et al.,: Is biological subtype prognostic of locoregional recurrence risk in women with pT1-2N0 breast cancer treated with mastectomy ? Int J Radiat Oncol Biol Phys 2014; 88: 57-64.
32. Malin JL, Kahn KL, Adams J, et al.,: Validity of cancer registry data for measuring the quality of breast cancer care. J Natl Cancer Inst 2002; 94: 835-844.
33. Du X, Freeman JL, Goodwin JS,: Information on radiation treatment in patients with breast cancer: the advantages of the linked medicare and SEER data. Surveillance, Epidemiology and End Results. J Clin Epidemiol 1999; 52: 463-470.
34. Walker GV, Giordano SH, Williams M, et al.,: Muddy water? Variation in reporting receipt of breast cancer radiation therapy by population-based tumor registries. Int J Radiat Oncol Biol Phys 2013; 86: 686-693.